Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Booth

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Bailliere'S Best Practice & Research. Clinical Haematology|June 17, 2000
Fibrinolysis and thrombosisN A Booth
Thrombosis and Haemostasis|February 24, 2001
TAFI meets the sticky endsN A Booth
Journal of Dentistry for Children|March 19, 2010
The use of general anesthesia in children's dentistryN A BOOTH
Experimental Cell Research|July 31, 1998
Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-golgi-independent pathwayH Ritchie, N A Booth
Bailliere'S Clinical Haematology|September 1, 1994
Fibrinolysis and thrombosisN A Booth, B Bennett
Thrombosis and Haemostasis|May 6, 1998
The distribution of the secreted and intracellular forms of plasminogen activator inhibitor 2 (PAI-2) in human peripheral blood monocytes is modulated by serumH Ritchie, N A Booth
British Journal of Haematology|March 1, 1982
Plasmin--alpha 2-antiplasmin complex as an indicator of in vivo fibrinolysisN A Booth, B Bennett
British Journal of Haematology|April 1, 1984
Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysisN A Booth, B Bennett
Thrombosis and Haemostasis|February 25, 1988
An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1)I R MacGregor, N A Booth
Journal of Enzyme Inhibition|January 1, 1991
The inhibitor reacting with a tumour cell surface protease can be exchanged with plasminogen activator inhibitor (PAI-1)F S Steven, N A Booth
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Bailliere'S Best Practice & Research. Clinical Haematology|June 17, 2000
Fibrinolysis and thrombosisN A Booth
Thrombosis and Haemostasis|February 24, 2001
TAFI meets the sticky endsN A Booth
Journal of Dentistry for Children|March 19, 2010
The use of general anesthesia in children's dentistryN A BOOTH
Experimental Cell Research|July 31, 1998
Secretion of plasminogen activator inhibitor 2 by human peripheral blood monocytes occurs via an endoplasmic reticulum-golgi-independent pathwayH Ritchie, N A Booth
Bailliere'S Clinical Haematology|September 1, 1994
Fibrinolysis and thrombosisN A Booth, B Bennett
Thrombosis and Haemostasis|May 6, 1998
The distribution of the secreted and intracellular forms of plasminogen activator inhibitor 2 (PAI-2) in human peripheral blood monocytes is modulated by serumH Ritchie, N A Booth
British Journal of Haematology|March 1, 1982
Plasmin--alpha 2-antiplasmin complex as an indicator of in vivo fibrinolysisN A Booth, B Bennett
British Journal of Haematology|April 1, 1984
Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysisN A Booth, B Bennett
Thrombosis and Haemostasis|February 25, 1988
An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1)I R MacGregor, N A Booth
Journal of Enzyme Inhibition|January 1, 1991
The inhibitor reacting with a tumour cell surface protease can be exchanged with plasminogen activator inhibitor (PAI-1)F S Steven, N A Booth
Pageof 9